Federal Register Recent Federal Regulation Documents - Justia Regulation Tracker - Justia Regulations Trackerhttps://regulations.justia.com/regulations/fedreg/agencies/department-of-health-and-human-services/2018/02/16?limit=200®isters=between&mode=atom2024-11-23T12:38:29-08:00Justia Inchttps://www.justia.com/Justia Regulations Trackerhttps://regulations.justia.com/images/justiafedregulations.gifCopyright 2011 Justia Inchttps://regulations.justia.com/regulations/fedreg/2018/02/16/2018-03245.htmlNotice - Determination of Regulatory Review Period for Purposes of Patent Extension; MOVANTIK2018-02-16T00:00:00-08:002018-02-16T00:00:00-08:002018-03245Noticehttps://www.gpo.gov/fdsys/pkg/FR-2018-02-16/pdf/2018-03245.pdfhttps://regulations.justia.com/regulations/fedreg/2018/02/16/2018-03243.htmlNotice - Agency Information Collection Activities: Proposed Collection; Comment Request2018-02-16T00:00:00-08:002018-02-16T00:00:00-08:002018-03243Noticehttps://www.gpo.gov/fdsys/pkg/FR-2018-02-16/pdf/2018-03243.pdfhttps://regulations.justia.com/regulations/fedreg/2018/02/16/2018-03237.htmlNotice - Endocrinologic and Metabolic Drugs Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments2018-02-16T00:00:00-08:002018-02-16T00:00:00-08:002018-03237Noticehttps://www.gpo.gov/fdsys/pkg/FR-2018-02-16/pdf/2018-03237.pdfhttps://regulations.justia.com/regulations/fedreg/2018/02/16/2018-03236.htmlNotice - Submission of Content Necessary for Bioresearch Monitoring Inspection Planning for the Center of Drug Evaluation and Research; Availability2018-02-16T00:00:00-08:002018-02-16T00:00:00-08:002018-03236Noticehttps://www.gpo.gov/fdsys/pkg/FR-2018-02-16/pdf/2018-03236.pdfhttps://regulations.justia.com/regulations/fedreg/2018/02/16/2018-03232.htmlNotice - Healthy Start Initiative: Eliminating Disparities in Perinatal Health Program Listening Session2018-02-16T00:00:00-08:002018-02-16T00:00:00-08:002018-03232Noticehttps://www.gpo.gov/fdsys/pkg/FR-2018-02-16/pdf/2018-03232.pdfhttps://regulations.justia.com/regulations/fedreg/2018/02/16/2018-03231.htmlNotice - Pediatric Advisory Committee; Establishment of a Public Docket; Request for Comments; Amendment of Notice2018-02-16T00:00:00-08:002018-02-16T00:00:00-08:002018-03231Noticehttps://www.gpo.gov/fdsys/pkg/FR-2018-02-16/pdf/2018-03231.pdfhttps://regulations.justia.com/regulations/fedreg/2018/02/16/2018-03230.htmlNotice - How To Prepare a Pre-Request for Designation; Guidance for Industry; Availability2018-02-16T00:00:00-08:002018-02-16T00:00:00-08:002018-03230Noticehttps://www.gpo.gov/fdsys/pkg/FR-2018-02-16/pdf/2018-03230.pdfhttps://regulations.justia.com/regulations/fedreg/2018/02/16/2018-03229.htmlNotice - Determination of Regulatory Review Period for Purposes of Patent Extension; HYMOVIS2018-02-16T00:00:00-08:002018-02-16T00:00:00-08:002018-03229Noticehttps://www.gpo.gov/fdsys/pkg/FR-2018-02-16/pdf/2018-03229.pdfhttps://regulations.justia.com/regulations/fedreg/2018/02/16/2018-03226.htmlNotice - Early Alzheimer's Disease: Developing Drugs for Treatment; Draft Guidance for Industry; Availability2018-02-16T00:00:00-08:002018-02-16T00:00:00-08:002018-03226Noticehttps://www.gpo.gov/fdsys/pkg/FR-2018-02-16/pdf/2018-03226.pdfhttps://regulations.justia.com/regulations/fedreg/2018/02/16/2018-03225.htmlNotice - Duchenne Muscular Dystrophy and Related Dystrophinopathies: Developing Drugs for Treatment; Guidance for Industry; Availability2018-02-16T00:00:00-08:002018-02-16T00:00:00-08:002018-03225Noticehttps://www.gpo.gov/fdsys/pkg/FR-2018-02-16/pdf/2018-03225.pdfhttps://regulations.justia.com/regulations/fedreg/2018/02/16/2018-03224.htmlNotice - Migraine: Developing Drugs for Acute Treatment; Guidance for Industry; Availability2018-02-16T00:00:00-08:002018-02-16T00:00:00-08:002018-03224Noticehttps://www.gpo.gov/fdsys/pkg/FR-2018-02-16/pdf/2018-03224.pdfhttps://regulations.justia.com/regulations/fedreg/2018/02/16/2018-03223.htmlNotice - Drugs for Treatment of Partial Onset Seizures: Full Extrapolation of Efficacy From Adults to Pediatric Patients 4 Years of Age and Older; Draft Guidance for Industry; Availability2018-02-16T00:00:00-08:002018-02-16T00:00:00-08:002018-03223Noticehttps://www.gpo.gov/fdsys/pkg/FR-2018-02-16/pdf/2018-03223.pdfhttps://regulations.justia.com/regulations/fedreg/2018/02/16/2018-03222.htmlNotice - Amyotrophic Lateral Sclerosis: Developing Drugs for Treatment; Draft Guidance for Industry; Availability2018-02-16T00:00:00-08:002018-02-16T00:00:00-08:002018-03222Noticehttps://www.gpo.gov/fdsys/pkg/FR-2018-02-16/pdf/2018-03222.pdfhttps://regulations.justia.com/regulations/fedreg/2018/02/16/2018-03218.htmlNotice - Determination of Regulatory Review Period for Purposes of Patent Extension; COTELLIC2018-02-16T00:00:00-08:002018-02-16T00:00:00-08:002018-03218Noticehttps://www.gpo.gov/fdsys/pkg/FR-2018-02-16/pdf/2018-03218.pdfhttps://regulations.justia.com/regulations/fedreg/2018/02/16/2018-03215.htmlNotice - Pediatric Medical Device Development; Public Meeting; Request for Comments2018-02-16T00:00:00-08:002018-02-16T00:00:00-08:002018-03215Noticehttps://www.gpo.gov/fdsys/pkg/FR-2018-02-16/pdf/2018-03215.pdfhttps://regulations.justia.com/regulations/fedreg/2018/02/16/2018-03188.htmlNotice - Determination That LOTENSIN HCT (Benazepril Hydrochloride; Hydrochlorothiazide) Oral Tablets, 5 Milligrams and 6.25 Milligrams, Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness2018-02-16T00:00:00-08:002018-02-16T00:00:00-08:002018-03188Noticehttps://www.gpo.gov/fdsys/pkg/FR-2018-02-16/pdf/2018-03188.pdfhttps://regulations.justia.com/regulations/fedreg/2018/02/16/2018-03186.htmlNotice - National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings2018-02-16T00:00:00-08:002018-02-16T00:00:00-08:002018-03186Noticehttps://www.gpo.gov/fdsys/pkg/FR-2018-02-16/pdf/2018-03186.pdf